Physician profile
Wanda Patrick Spuhler
NPI 1083671267
$1,467.88
in general payments reported to CMS, 2019-2025
18 companies · $20.21 in 2025
The $20.21 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.63 · 2020: $411 · 2021: $271 · 2022: $226 · 2023: $215 · 2024: $285 · 2025: $20.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $519.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $403.19 | 2021-2023 | Vraylar, Rinvoq |
| Medtronic, INC. | $158.14 | 2024 | Corevalve Evolut R |
| Genzyme Corporation | $126.83 | 2024 | |
| Lilly USA, LLC | $122.28 | 2020-2025 | Mounjaro |
| Kowa Pharmaceuticals America, INC. | $116.62 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $98.39 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $69.22 | 2020-2021 | |
| Novo Nordisk INC | $67.70 | 2020-2021 | |
| Amarin Pharma, INC. | $66.00 | 2020 | |
| Abbott Laboratories | $55.24 | 2022-2023 | Freestyle Libre 3 |
| Pfizer INC. | $47.70 | 2020-2022 | |
| Amgen INC. | $40.57 | 2020 | |
| Astellas Pharma US INC | $22.37 | 2020 | |
| Genentech USA, INC. | $20.63 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $14.16 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $13.69 | 2020 | |
| Sanofi-Aventis U.S. LLC | $12.64 | 2020 | |
| Allergan, INC. | $12.51 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wanda Spuhler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.